PDB Short entry for 1QNH
HEADER    ISOMERASE/IMMUNOSUPPRESSANT             14-OCT-99   1QNH              
TITLE     PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH      
TITLE    2 CYCLOSPORIN A                                                        
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;                       
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: PPIASE, ROTAMASE, CYCLOPHILIN A;                            
COMPND   5 EC: 5.2.1.8;                                                         
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: CYCLOSPORIN A;                                             
COMPND   9 CHAIN: C, D;                                                         
COMPND  10 SYNONYM: CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE;                    
COMPND  11 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM;                          
SOURCE   3 ORGANISM_TAXID: 5833;                                                
SOURCE   4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   5 EXPRESSION_SYSTEM_TAXID: 469008;                                     
SOURCE   6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);                                 
SOURCE   7 MOL_ID: 2;                                                           
SOURCE   8 SYNTHETIC: YES;                                                      
SOURCE   9 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM;                         
SOURCE  10 ORGANISM_TAXID: 29910                                                
KEYWDS    ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, 
KEYWDS   2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    M.R.PETERSON,D.R.HALL,W.N.HUNTER                                      
REVDAT   5   13-DEC-23 1QNH    1       LINK                                     
REVDAT   4   13-JUL-11 1QNH    1       VERSN                                    
REVDAT   3   24-FEB-09 1QNH    1       VERSN                                    
REVDAT   2   23-JUL-02 1QNH    1       HEADER                                   
REVDAT   1   13-OCT-00 1QNH    0                                                
JRNL        AUTH   M.R.PETERSON,D.R.HALL,M.BERRIMAN,G.A.LEONARD,A.H.FAIRLAMB,   
JRNL        AUTH 2 W.N.HUNTER                                                   
JRNL        TITL   THE THREE-DIMENSIONAL STRUCTURE OF A PLASMODIUM FALCIPARUM   
JRNL        TITL 2 CYCLOPHILIN IN COMPLEX WITH THE POTENT ANTI-MALARIAL         
JRNL        TITL 3 CYCLOSPORIN A                                                
JRNL        REF    J.MOL.BIOL.                   V. 298   123 2000              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   10756109                                                     
JRNL        DOI    10.1006/JMBI.2000.3633                                       
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   M.BERRIMAN,A.H.FAIRLAMB                                      
REMARK   1  TITL   DETAILED CHARACTERIZATION OF A CYCLOPHILIN FROM THE HUMAN    
REMARK   1  TITL 2 MALARIA PARASITE PLASMODIUM FALCIPARUM                       
REMARK   1  REF    BIOCHEM.J.                    V. 334   437 1998              
REMARK   1  REFN                   ISSN 0264-6021                               
REMARK   1  PMID   9716503                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.10 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 0.5                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : NULL                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 24.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 98.2                           
REMARK   3   NUMBER OF REFLECTIONS             : 24606                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.170                           
REMARK   3   FREE R VALUE                     : 0.210                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.000                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 2471                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 49                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.10                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.11                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 390                          
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2270                       
REMARK   3   BIN FREE R VALUE                    : 0.2420                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 10.00                        
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 53                           
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2775                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 213                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 34.20                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 26.60                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.006                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.300                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            
REMARK   3   IMPROPER ANGLES        (DEGREES) : NULL                            
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 0.917 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 1.345 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 1.548 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 2.021 ; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : NULL                                                 
REMARK   3   KSOL        : NULL                                                 
REMARK   3   BSOL        : NULL                                                 
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM                              
REMARK   3  PARAMETER FILE  2  : WATER_REP.PARAM                                
REMARK   3  PARAMETER FILE  3  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : WATER.TOP                                      
REMARK   3  TOPOLOGY FILE  3   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: REFINEMENT AT EARLY STAGES UTILISED X     
REMARK   3  -PLOR AND REFMAC AND NCS RESTRAINTS WERE RELEASED AT THE FINAL      
REMARK   3  STAGES OF REFINEMENT THE SIDE CHAINS OF THE FOLLOWING RESIDUES      
REMARK   3  ARE DISORDERED ASN A 15, LYS A 51, LYS A 155, ARG B 49, LYS B 51,   
REMARK   3  ARG B 88, LYS B 155, LYS B 160 SER A 2 IS DISORDERED AND NOT        
REMARK   3  OBSERVED                                                            
REMARK   4                                                                      
REMARK   4 1QNH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-OCT-99.                  
REMARK 100 THE DEPOSITION ID IS D_1290004212.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : NULL                               
REMARK 200  TEMPERATURE           (KELVIN) : 277.0                              
REMARK 200  PH                             : 7.70                               
REMARK 200  NUMBER OF CRYSTALS USED        : 4                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : BM14                               
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.98                               
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : FUJI BAS-2000 IMAGE PLATE          
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 24606                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.100                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 24.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.2                               
REMARK 200  DATA REDUNDANCY                : 5.000                              
REMARK 200  R MERGE                    (I) : 0.07600                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 17.8000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.15                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 92.7                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 2.00                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.21300                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 3.700                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: PDB ENTRY 1CWA                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 55.00                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.70                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2                        
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z                                                 
REMARK 290       3555   -X+1/2,Y+1/2,-Z                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000       46.05500            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       57.56000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       46.05500            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       57.56000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 9520 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.2 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 9470 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.4 KCAL/MOL                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.                               
REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES)          
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: CYCLOSPORIN A                                                
REMARK 400   CHAIN: C, D                                                        
REMARK 400   COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11                
REMARK 400   DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.                
REMARK 400                CYCLIZATION IS ACHIEVED BY LINKING THE N- AND         
REMARK 400                THE C- TERMINI.                                       
REMARK 400                                                                      
REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT   
REMARK 400 CLASS.                                                               
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: CYCLOSPORIN A                                                
REMARK 400   CHAIN: C, D                                                        
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION    
REMARK 400                IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI.     
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     SER A     2                                                      
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     ASN A  15    CG   OD1  ND2                                       
REMARK 470     LYS A  51    CG   CD   CE   NZ                                   
REMARK 470     LYS A 155    CG   CD   CE   NZ                                   
REMARK 470     ARG B  49    CG   CD   NE   CZ   NH1  NH2                        
REMARK 470     LYS B  51    CG   CD   CE   NZ                                   
REMARK 470     ARG B  88    CG   CD   NE   CZ   NH1  NH2                        
REMARK 470     LYS B 155    CG   CD   CE   NZ                                   
REMARK 470     LYS B 160    CG   CD   CE   NZ                                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A  15       -1.24     71.92                                   
REMARK 500    ARG A  49     -122.03    -79.03                                   
REMARK 500    PHE A  67      -80.25   -138.07                                   
REMARK 500    SER A 116      -92.44   -140.76                                   
REMARK 500    ARG B  49     -137.02    -93.77                                   
REMARK 500    PHE B  67      -81.80   -137.50                                   
REMARK 500    SER B 116      -92.82   -132.95                                   
REMARK 500    MLE C 210     -166.69   -100.48                                   
REMARK 500    MLE D 210     -167.73   -104.75                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A2008        DISTANCE =  6.15 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CYCLOSPORIN A          
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOSPORIN A          
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1BCK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 C                                                                    
REMARK 900 RELATED ID: 1C5F   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI  
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 1CSA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH      
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1CWA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 1CWB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 5                                          
REMARK 900 RELATED ID: 1CWC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 D                                                                    
REMARK 900 RELATED ID: 1CWH   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A MODIFIED AT POSITION 7                                             
REMARK 900 RELATED ID: 1CWI   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITION 7                                          
REMARK 900 RELATED ID: 1CWJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7.                                  
REMARK 900 RELATED ID: 1CWK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7.                                  
REMARK 900 RELATED ID: 1CWL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 8                                          
REMARK 900 RELATED ID: 1CWO   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9                                  
REMARK 900 RELATED ID: 1CYA   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A 
REMARK 900 RELATED ID: 1CYB   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A 
REMARK 900 RELATED ID: 1CYN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 1IKF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX                         
REMARK 900 RELATED ID: 1M63   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX     
REMARK 900 RELATED ID: 1MF8   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN          
REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A                                        
REMARK 900 RELATED ID: 1MIK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 6                                          
REMARK 900 RELATED ID: 1QNG   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED     
REMARK 900 WITH CYCLOSPORIN A                                                   
REMARK 900 RELATED ID: 1XQ7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH    
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2ESL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2OJU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2POY   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A    
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2RMA   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN  
REMARK 900 A                                                                    
REMARK 900 RELATED ID: 2RMB   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED     
REMARK 900 CYCLOSPORIN A AT POSITION 5                                          
REMARK 900 RELATED ID: 2RMC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 2WFJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G        
REMARK 900 COMPLEXED WITH CYCLOSPORIN A                                         
REMARK 900 RELATED ID: 2X2C   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A 
REMARK 900 RELATED ID: 2X7K   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A             
REMARK 900 RELATED ID: 2Z6W   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH             
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3BO7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII           
REMARK 900 COMPLEXED WIT CYCLOSPORIN A                                          
REMARK 900 RELATED ID: 3CYS   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH         
REMARK 900 CYCLOSPORIN A                                                        
REMARK 900 RELATED ID: 3EOV   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED  
REMARK 900 WITH CYCLOSPORIN A                                                   
DBREF  1QNH A    2   171  UNP    Q25756   Q25756           2    171             
DBREF  1QNH B    2   171  UNP    Q25756   Q25756           2    171             
DBREF  1QNH C  201   211  NOR    NOR00033 NOR00033         1     11             
DBREF  1QNH D  201   211  NOR    NOR00033 NOR00033         1     11             
SEQADV 1QNH LEU A  120  UNP  Q25756    PHE   120 ENGINEERED MUTATION            
SEQADV 1QNH TRP A  171  UNP  Q25756    LEU   171 ENGINEERED MUTATION            
SEQADV 1QNH LEU B  120  UNP  Q25756    PHE   120 ENGINEERED MUTATION            
SEQADV 1QNH TRP B  171  UNP  Q25756    LEU   171 ENGINEERED MUTATION            
SEQRES   1 A  170  SER LYS ARG SER LYS VAL PHE PHE ASP ILE SER ILE ASP          
SEQRES   2 A  170  ASN SER ASN ALA GLY ARG ILE ILE PHE GLU LEU PHE SER          
SEQRES   3 A  170  ASP ILE THR PRO ARG THR CYS GLU ASN PHE ARG ALA LEU          
SEQRES   4 A  170  CYS THR GLY GLU LYS ILE GLY SER ARG GLY LYS ASN LEU          
SEQRES   5 A  170  HIS TYR LYS ASN SER ILE PHE HIS ARG ILE ILE PRO GLN          
SEQRES   6 A  170  PHE MET CYS GLN GLY GLY ASP ILE THR ASN GLY ASN GLY          
SEQRES   7 A  170  SER GLY GLY GLU SER ILE TYR GLY ARG SER PHE THR ASP          
SEQRES   8 A  170  GLU ASN PHE ASN MET LYS HIS ASP GLN PRO GLY LEU LEU          
SEQRES   9 A  170  SER MET ALA ASN ALA GLY PRO ASN THR ASN SER SER GLN          
SEQRES  10 A  170  PHE LEU ILE THR LEU VAL PRO CYS PRO TRP LEU ASP GLY          
SEQRES  11 A  170  LYS HIS VAL VAL PHE GLY LYS VAL ILE GLU GLY MET ASN          
SEQRES  12 A  170  VAL VAL ARG GLU MET GLU LYS GLU GLY ALA LYS SER GLY          
SEQRES  13 A  170  TYR VAL LYS ARG SER VAL VAL ILE THR ASP CYS GLY GLU          
SEQRES  14 A  170  TRP                                                          
SEQRES   1 B  170  SER LYS ARG SER LYS VAL PHE PHE ASP ILE SER ILE ASP          
SEQRES   2 B  170  ASN SER ASN ALA GLY ARG ILE ILE PHE GLU LEU PHE SER          
SEQRES   3 B  170  ASP ILE THR PRO ARG THR CYS GLU ASN PHE ARG ALA LEU          
SEQRES   4 B  170  CYS THR GLY GLU LYS ILE GLY SER ARG GLY LYS ASN LEU          
SEQRES   5 B  170  HIS TYR LYS ASN SER ILE PHE HIS ARG ILE ILE PRO GLN          
SEQRES   6 B  170  PHE MET CYS GLN GLY GLY ASP ILE THR ASN GLY ASN GLY          
SEQRES   7 B  170  SER GLY GLY GLU SER ILE TYR GLY ARG SER PHE THR ASP          
SEQRES   8 B  170  GLU ASN PHE ASN MET LYS HIS ASP GLN PRO GLY LEU LEU          
SEQRES   9 B  170  SER MET ALA ASN ALA GLY PRO ASN THR ASN SER SER GLN          
SEQRES  10 B  170  PHE LEU ILE THR LEU VAL PRO CYS PRO TRP LEU ASP GLY          
SEQRES  11 B  170  LYS HIS VAL VAL PHE GLY LYS VAL ILE GLU GLY MET ASN          
SEQRES  12 B  170  VAL VAL ARG GLU MET GLU LYS GLU GLY ALA LYS SER GLY          
SEQRES  13 B  170  TYR VAL LYS ARG SER VAL VAL ILE THR ASP CYS GLY GLU          
SEQRES  14 B  170  TRP                                                          
SEQRES   1 C   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
SEQRES   1 D   11  DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA                  
MODRES 1QNH MLE C  202  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MLE C  203  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MVA C  204  VAL  N-METHYLVALINE                                     
MODRES 1QNH BMT C  205  THR                                                     
MODRES 1QNH ABA C  206  ALA  ALPHA-AMINOBUTYRIC ACID                            
MODRES 1QNH SAR C  207  GLY  SARCOSINE                                          
MODRES 1QNH MLE C  208  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MLE C  210  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MLE D  202  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MLE D  203  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MVA D  204  VAL  N-METHYLVALINE                                     
MODRES 1QNH BMT D  205  THR                                                     
MODRES 1QNH ABA D  206  ALA  ALPHA-AMINOBUTYRIC ACID                            
MODRES 1QNH SAR D  207  GLY  SARCOSINE                                          
MODRES 1QNH MLE D  208  LEU  N-METHYLLEUCINE                                    
MODRES 1QNH MLE D  210  LEU  N-METHYLLEUCINE                                    
HET    DAL  C 201       5                                                       
HET    MLE  C 202       9                                                       
HET    MLE  C 203       9                                                       
HET    MVA  C 204       8                                                       
HET    BMT  C 205      13                                                       
HET    ABA  C 206       6                                                       
HET    SAR  C 207       5                                                       
HET    MLE  C 208       9                                                       
HET    MLE  C 210       9                                                       
HET    DAL  D 201       5                                                       
HET    MLE  D 202       9                                                       
HET    MLE  D 203       9                                                       
HET    MVA  D 204       8                                                       
HET    BMT  D 205      13                                                       
HET    ABA  D 206       6                                                       
HET    SAR  D 207       5                                                       
HET    MLE  D 208       9                                                       
HET    MLE  D 210       9                                                       
HETNAM     DAL D-ALANINE                                                        
HETNAM     MLE N-METHYLLEUCINE                                                  
HETNAM     MVA N-METHYLVALINE                                                   
HETNAM     BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE                  
HETNAM     ABA ALPHA-AMINOBUTYRIC ACID                                          
HETNAM     SAR SARCOSINE                                                        
FORMUL   3  DAL    2(C3 H7 N O2)                                                
FORMUL   3  MLE    8(C7 H15 N O2)                                               
FORMUL   3  MVA    2(C6 H13 N O2)                                               
FORMUL   3  BMT    2(C10 H19 N O3)                                              
FORMUL   3  ABA    2(C4 H9 N O2)                                                
FORMUL   3  SAR    2(C3 H7 N O2)                                                
FORMUL   5  HOH   *213(H2 O)                                                    
HELIX    1   1 THR A   30  GLY A   43  1                                  14    
HELIX    2   2 CYS A  126  ASP A  130  5                                   5    
HELIX    3   3 GLY A  142  LYS A  151  1                                  10    
HELIX    4   4 THR B   30  GLY B   43  1                                  14    
HELIX    5   5 CYS B  126  ASP B  130  5                                   5    
HELIX    6   6 GLY B  142  LYS B  151  1                                  10    
SHEET    1  AA 8 ARG A  62  ILE A  64  0                                        
SHEET    2  AA 8 MET A  68  GLY A  71 -1  O  MET A  68   N  ILE A  64           
SHEET    3  AA 8 PHE A 119  THR A 122 -1  O  PHE A 119   N  GLY A  71           
SHEET    4  AA 8 LEU A 104  MET A 107 -1  O  LEU A 104   N  THR A 122           
SHEET    5  AA 8 VAL A 135  GLU A 141 -1  N  PHE A 136   O  LEU A 105           
SHEET    6  AA 8 SER A  16  LEU A  25 -1  O  ILE A  22   N  ILE A 140           
SHEET    7  AA 8 LYS A   6  ILE A  13 -1  O  VAL A   7   N  PHE A  23           
SHEET    8  AA 8 VAL A 163  GLU A 170 -1  O  VAL A 164   N  SER A  12           
SHEET    1  AB 2 LYS A  45  ILE A  46  0                                        
SHEET    2  AB 2 ASN A  52  LEU A  53 -1  O  LEU A  53   N  LYS A  45           
SHEET    1  BA 8 ARG B  62  ILE B  64  0                                        
SHEET    2  BA 8 MET B  68  GLY B  71 -1  O  MET B  68   N  ILE B  64           
SHEET    3  BA 8 PHE B 119  THR B 122 -1  O  PHE B 119   N  GLY B  71           
SHEET    4  BA 8 LEU B 104  MET B 107 -1  O  LEU B 104   N  THR B 122           
SHEET    5  BA 8 VAL B 135  GLU B 141 -1  N  PHE B 136   O  LEU B 105           
SHEET    6  BA 8 SER B  16  LEU B  25 -1  O  ILE B  22   N  ILE B 140           
SHEET    7  BA 8 SER B   5  ILE B  13 -1  O  SER B   5   N  LEU B  25           
SHEET    8  BA 8 VAL B 163  GLU B 170 -1  O  VAL B 164   N  SER B  12           
LINK         C   DAL C 201                 N   MLE C 202     1555   1555  1.38  
LINK         N   DAL C 201                 C   ALA C 211     1555   1555  1.34  
LINK         C   MLE C 202                 N   MLE C 203     1555   1555  1.35  
LINK         C   MLE C 203                 N   MVA C 204     1555   1555  1.34  
LINK         C   MVA C 204                 N   BMT C 205     1555   1555  1.37  
LINK         C   BMT C 205                 N   ABA C 206     1555   1555  1.34  
LINK         C   ABA C 206                 N   SAR C 207     1555   1555  1.36  
LINK         C   SAR C 207                 N   MLE C 208     1555   1555  1.37  
LINK         C   MLE C 208                 N   VAL C 209     1555   1555  1.33  
LINK         C   VAL C 209                 N   MLE C 210     1555   1555  1.35  
LINK         C   MLE C 210                 N   ALA C 211     1555   1555  1.33  
LINK         C   DAL D 201                 N   MLE D 202     1555   1555  1.38  
LINK         N   DAL D 201                 C   ALA D 211     1555   1555  1.35  
LINK         C   MLE D 202                 N   MLE D 203     1555   1555  1.34  
LINK         C   MLE D 203                 N   MVA D 204     1555   1555  1.34  
LINK         C   MVA D 204                 N   BMT D 205     1555   1555  1.36  
LINK         C   BMT D 205                 N   ABA D 206     1555   1555  1.34  
LINK         C   ABA D 206                 N   SAR D 207     1555   1555  1.35  
LINK         C   SAR D 207                 N   MLE D 208     1555   1555  1.37  
LINK         C   MLE D 208                 N   VAL D 209     1555   1555  1.33  
LINK         C   VAL D 209                 N   MLE D 210     1555   1555  1.35  
LINK         C   MLE D 210                 N   ALA D 211     1555   1555  1.33  
SITE     1 AC1 14 ARG A  62  PHE A  67  GLN A  70  GLY A  79                    
SITE     2 AC1 14 ALA A 108  ASN A 109  GLN A 118  LEU A 120                    
SITE     3 AC1 14 TRP A 128  HIS A 133  ALA B 110  HOH C2002                    
SITE     4 AC1 14 HOH C2003  BMT D 205                                          
SITE     1 AC2 19 ARG A  88  ALA A 110  HOH A2037  ARG B  62                    
SITE     2 AC2 19 PHE B  67  GLN B  70  GLY B  79  ALA B 108                    
SITE     3 AC2 19 ASN B 109  GLN B 118  LEU B 120  TRP B 128                    
SITE     4 AC2 19 LEU B 129  HIS B 133  ABA C 206  SAR C 207                    
SITE     5 AC2 19 HOH D2002  HOH D2003  HOH D2004                               
CRYST1   92.110  115.120   39.020  90.00  90.00  90.00 P 21 21 2     8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.010857  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.008687  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.025628        0.00000                         
MTRIX1   1 -0.163350 -0.986060  0.031820       63.67295    1                    
MTRIX2   1  0.964890 -0.166400 -0.203210       72.66035    1                    
MTRIX3   1  0.205670 -0.002500  0.978620       11.18299    1